Brandon D. Le

Brandon D. Le

Auto-generated profile, based on publicly available information

Brandon D. Le

Department of Genetics, University of North Carolina at Chapel Hill; Chapel Hill

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2019 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Open access
PDF file
BLBrandon D. Le
Brandon D. Le
JSJason L. Stein
Jason L. Stein
Imaging genetics aims to identify genetic variants associated with the structure and function of the human brain. Recently, collaborative consortia have been successful in this goal, identifying and replicating common genetic variants influencing gross human brain structure as measured through magnetic resonance imaging. In this review, we contextualize imaging genetic associations as one important link in understanding the causal chain from genetic variant to increased risk for neuropsychiatric disorders. We provide examples in other fields of how identifying genetic variant associations to disease and multiple phenotypes along the causal chain has revealed a mechanistic understanding of disease risk, with implications for how imaging genetics can be similarly applied. We discuss current findings in the imaging genetics research domain, including that common genetic variants can have a slightly larger effect on brain structure than on risk for disorders like schizophrenia, indicating a somewhat simpler genetic architecture. Also, gross brain structure measurements share a genetic basis with some, but not all, neuropsychiatric disorders, invalidating the previously held belief that they are broad endophenotypes, yet pinpointing brain regions likely involved in the pathology of specific disorders. Finally, we suggest that in order to build a more detailed mechanistic understanding of the effects of genetic variants on the brain, future directions in imaging genetics research will require observations of cellular and synaptic structure in specific brain regions beyond the resolution of magnetic resonance imaging. We expect that integrating genetic associations at biological levels from synapse to sulcus will reveal specific causal pathways impacting risk for neuropsychiatric disorders.

3 January 2008 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
NSNicholas S. R. Sanderson
Nicholas S. R. Sanderson
BLBrandon Le
Brandon Le
ZZZifei Zhou
Zifei Zhou
DCDavid Crews
David Crews

14 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JVJordan M Valone
Jordan M Valone
BLBrandon D Le
Brandon D Le
NMNana Matoba
Nana Matoba
JMJessica T Mory
Jessica T Mory
JWJustin M Wolter
Justin M Wolter
JSJason L Stein
Jason L Stein
Gene by treatment (GxT) interactions likely contribute to variability in clinical response, but are difficult to identify in population studies. Here, we applied psychiatric and neurological disorder treatments to a genotyped population of human neural progenitors (n=83 donors) and measured molecular responses on chromatin accessibility and gene expression. Gene regulatory responses to valproic acid (VPA), which is also a prenatal risk factor for autism, and lithium were highly enriched in genetic risk for psychiatric disorders, demonstrating the convergence of environmental and genetic factors. Genetic variation impacted molecular response to these drugs at over 1,000 loci, a subset of which modulated the impacts of psychiatric disorder risk variants. Finally, transcriptome-wide association revealed enzymes involved with folate metabolism during VPA exposure impact cognitive ability, a pathway previously shown to alleviate the negative impacts of this exposure. The “GxT in a dish” approach identified a validated treatment pathway, supporting its broad utility.

6 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
YHYuriko Harigaya
Yuriko Harigaya
NMNana Matoba
Nana Matoba
BLBrandon D. Le
Brandon D. Le
JVJordan M. Valone
Jordan M. Valone
JSJason L. Stein
Jason L. Stein
WVWilliam Valdar
William Valdar
Genetic variation can modulate response to treatment (G×T) or environmental stimuli (G×E), both of which may be highly consequential in biomedicine. An effective approach to identifying G×T signals and gaining insight into molecular mechanisms is mapping quantitative trait loci (QTL) of molecular count phenotypes, such as gene expression and chromatin accessibility, under multiple treatment conditions, which is termed response molecular QTL mapping. Although standard approaches evaluate the interaction between genetics and treatment conditions, they do not distinguish between meaningful interpretations such as whether a genetic effect is only observed in the treated condition or whether a genetic effect is observed but accentuated in the treated condition. To address this gap, we have developed a downstream method for classifying response molecular QTLs into subclasses with meaningful genetic interpretations. Our method uses Bayesian model selection and assigns posterior probabilities to different types of G×T interactions for a given feature-SNP pair. We compare linear and nonlinear regression of log-scale counts, noting that the latter accounts for an expected biological relationship between the genotype and the molecular count phenotype. Through simulation and application to existing datasets of molecular response QTLs, we show that our method provides an intuitive and well-powered framework to report and interpret G×T interactions. We provide a software package, ClassifyGxT, which is available at https://github.com/yharigaya/classifygxt . Author summary: Responses to treatment, such as drug, therapeutic intervention, and infection, can vary across individuals at least in part due to their genetic backgrounds. This phenomenon can be conceptualized as a manifestation of gene-by-treatment (G×T) or gene-by-environment (G×E) interactions, which refer to non-additive effects of genotype and treatment on traits and phenotypes. An understading of G×T or G×E interactions can potentially improve strategies for prevention and treatment of diseases, for example by selecting treatments for which a patient is most likely to respond given their genetic information, or enhanced screening for individuals most susceptible to environmental exposures. An effective approach to G×T discovery is response quantitative trait loci (QTL) mapping, where the effect of the treatment on the association between the genotype and phenotype is examined using a linear regression model including the genotype, treatment, and G×T interaction terms. Despite its effectiveness in identifying a large number of associations, the response QTL mapping relies on hypothesis testing, which does not provide classification of different types of G×T interactions. Herein, we propose a use of Bayesian model selection to classify the G×T types of response QTLs and provide a software package for this method. In addition to standard linear regression, our package provides an option to use nonlinear regression that is suited for molecular count phenotypes, such as gene expression and chromatin accessibility, measured by sequencing-based techniques. It also provides an option to use mixed effect models to accommodate replicate measurements per donor, which are common in data generated in in-vitro cell systems.